BackSunshine Biopharma Overview

Sunshine Biopharma Long Term Debt

Track Sunshine Biopharma's long-term debt ($540K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$535614.00
↓ 25.84% YoYΔ $-186585.00 vs prior year quarter

Peer average

Loading

Sunshine Biopharma Long Term Debt History

Loading

Sunshine Biopharma vs. peers: Long Term Debt Comparison

Loading

Sunshine Biopharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sunshine Biopharma (SBFM) FAQ

Sunshine Biopharma (SBFM) currently reports a long-term debt of $540K as of March 2026. That compares with $720K in the prior-year period — down 25.8% year over year. Use the charts on this page to explore Sunshine Biopharma's long-term debt history and peer comparisons.

Sunshine Biopharma's long-term debt decreased from $720K to $540K — a 25.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sunshine Biopharma reported $540K in long-term debt as of March 2026. That compares with $720K in the prior-year period — down 25.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $540K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sunshine Biopharma, and consider following SBFM for alerts when major investors trade the stock.

Sunshine Biopharma is classified in the Healthcare sector. On long-term debt, it currently shows $540K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SBFM with unrelated industries.